Publicacións en colaboración con investigadores/as de Hospital Universitario Nuestra Señora de Candelaria (62)

2024

  1. Comment on “Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease”

    Archivos de Bronconeumologia

  2. Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry

    Haematologica, Vol. 109, Núm. 1, pp. 115-128

  3. Oxygen therapy could improve survival in patients with early desaturation in the 6-minute walk test: A post hoc analysis

    Respirology

  4. [Translated article] Requirements for Accessing New Dermatology Drugs in Spain: Results of the EQUIDAD Study

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 3, pp. T237-T245

2023

  1. A Novel Figure and Algorithm for the GOLD-ABE Classification: Additional Comments

    Archivos de Bronconeumologia

  2. Classification of the Severity of COPD Exacerbations in Hospitalized Patients According to Rome vs GesEPOC Criteria

    Archivos de Bronconeumologia, Vol. 59, Núm. 1, pp. 57-58

  3. Development and validation of a prognostic index (BODEXS90) for mortality in stable chronic obstructive pulmonary disease

    Pulmonology, Vol. 29, Núm. 4, pp. 276-283

  4. Early Desaturation During 6-Minute Walk Test is a Predictor of Mortality in COPD

    Lung, Vol. 201, Núm. 2, pp. 217-224

  5. Impact of Oral Antidiabetics Agents in the Prevention of COPD Exacerbations

    Archivos de Bronconeumologia

  6. Nocturnal Dyspnea During Severe Exacerbations Is Associated With Mortality Risk in COPD

    Respiratory care, Vol. 68, Núm. 3, pp. 413-416

  7. Real-World Safety and Efficacy Clinical Data of an Improved Allergen-Specific Immunotherapy Product for the Treatment of Bee Venom Allergy

    Vaccines, Vol. 11, Núm. 5

  8. Relationship Between the Summation of GesEPOC High-Risk Factors and the Presence of Cardiovascular Disease

    Archivos de Bronconeumologia, Vol. 59, Núm. 6, pp. 403-405

  9. Spanish cardiac catheterization and coronary intervention registry. 32nd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2022)

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 1021-1031

  10. The Relevance of Comorbidities in the Persistence of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease

    Open Respiratory Archives, Vol. 5, Núm. 3

  11. Ultrasound assessment of diaphragmatic dynamics in patients with chronic obstructive pulmonary disease after treatment with indacaterol/glycopyrronium

    Revista Clinica Espanola, Vol. 223, Núm. 4, pp. 216-222

2022

  1. A new, three-dimensional approach to the GOLD COPD assessment tool

    Respiratory Medicine and Research, Vol. 81

  2. Adjusting RFR by Predictors of Disagreement, “The Adjusted RFR”: An Alternative Methodology to Improve the Diagnostic Capacity of Coronary Indices

    Arquivos Brasileiros de Cardiologia, Vol. 119, Núm. 5, pp. 705-713

  3. Benefits of a comprehensive care model in patients with heart failure and preserved ejection fraction: The UMIPIC program

    Revista Clinica Espanola, Vol. 222, Núm. 6, pp. 339-347

  4. Evaluation of the multimorbidity network and its relationship with clinical phenotypes in chronic obstructive pulmonary disease: The GALAXIA study

    Clinical Respiratory Journal, Vol. 16, Núm. 7, pp. 504-512

  5. Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study)

    Lung Cancer, Vol. 173, pp. 83-93